Abcam

E422482

Abcam is a biotechnology company specializing in the production and distribution of research-grade antibodies and related reagents for life science research.

All labels observed (2)

Label Occurrences
Abcam canonical 1
Abcam Inc. 1

How this entity was disambiguated

Statements (49)

Predicate Object
instanceOf biotechnology company
public company
acquiredBy Danaher Corporation
acquisitionAnnounced 2023
coreProduct ELISA kits
cellular imaging reagents
immunoassay reagents
protein reagents
recombinant antibodies
research-grade antibodies
countryOfOrigin United Kingdom
focusArea antibody production
antibody validation
cell biology research
epigenetics research
immunology research
neuroscience research
proteomics research
foundedBy David Cleevely
Jonathan Milner
Tony Kouzarides
hasBusinessModel e-commerce distribution of reagents
hasOfficeLocation Amsterdam, Netherlands
linked to: Amsterdam

Berlin, Germany
linked to: Berlin

Cambridge, Massachusetts, United States
Hong Kong
linked to: Hong Kong, China

Melbourne, Australia
Paris, France
linked to: Paris

Shanghai, China
linked to: Shanghai

Singapore
Tokyo, Japan
linked to: Tokyo

Toronto, Canada
linked to: Toronto
hasResearchTool Knockout-validated antibodies
Recombinant monoclonal antibodies
hasSubsidiary Abcam Inc.
linked to: Abcam
headquartersLocation Cambridge, United Kingdom
linked to: Cambridge, England
inception 1998
industry biotechnology
life sciences
research reagents
listedOn AIM
offersService bulk and OEM supply of reagents
custom antibody production
technical support for antibody use
servesIndustry academic research
biotechnology industry
pharmaceutical industry
tickerSymbol ABC
website https://www.abcam.com

How these facts were elicited

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Abcam hasSubsidiary Abcam Inc.
linked to: Abcam